Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin-Reference-Cited by-同舟云学术

Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin

Published:2020-01-23 Issue:5 Volume:86 Page:944-957
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Bhagunde Pratik¹,Colon‐Gonzalez Francheska¹,Liu Yang¹,Wu Jin¹,Xu Shiyao Sherrie¹,Garrett Graigory¹,Jumes Patricia¹,Lasseter Kenneth²,Marbury Thomas³,Rizk Matthew L.¹,Lala Mallika¹,Rhee Elizabeth G.¹,Butterton Joan R.¹,Boundy Keith¹

Affiliation:

1. Merck & Co., Inc. Kenilworth NJ USA

2. Clinical Pharmacology of Miami, LLC Miami FL USA

3. Orlando Clinical Research Center Orlando FL USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14204

Reference29 articles.

1. A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011

2. Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae

3. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals — United States, 2014

4. World Health Organization.Worldwide country situation analysis: response to antimicrobial resistance.2015.http://www.who.int/drugresistance/documents/situationanalysis/en/. Accessed October 9 2017.

5. Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria;Antibiotics;2024-03-15

2. New Perspectives on Antimicrobial Agents: Imipenem-Relebactam;Antimicrobial Agents and Chemotherapy;2022-07-19

3. Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians;Pharmaceuticals;2022-04-12

4. Role of organic anion transporter 3 in the renal excretion of biapenem and potential drug-drug interactions;European Journal of Pharmaceutical Sciences;2021-07

5. Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors;Expert Review of Clinical Pharmacology;2021-04-29